Syntropic Medical was founded in 2023 with the goal of transforming mental health treatment through innovative, non-invasive technology. The company is developing a wearable medical device that uses flickering light therapy to treat individuals with Major Depressive Disorder (MDD). Designed like a pair of safety goggles, the device delivers light-based neurostimulation through the eyes to enhance neuroplasticity in the brain. By targeting the underlying neurobiological mechanisms of MDD rather than just alleviating symptoms, Syntropic Medical aims to provide a more effective, accessible, and science-driven solution for depression treatment.